W. Utz

发表

Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype.

P. Gmeiner, H. Hübner, C. Haubmann, 2000, Journal of medicinal chemistry.

CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.

F. Boeckler, P. Gmeiner, H. Hübner, 2005, Journal of medicinal chemistry.

Lignans and neolignans from Krameria parvifolia

W. Utz, H. Achenbach, E. M. Touché, 1996 .

Neolignans and nor-neolignans from Krameria paucifolia

W. Utz, H. Achenbach, X. Domínguez, 1993 .

Neolignans, Norneolignans, and Other Components from Krameria sonorae 1

M. Piattelli, W. Utz, C. Geraci, 1992, Planta medica.

Lignans and nor-neolignans from Krameria interior

W. Utz, H. Achenbach, X. Domínguez, 1990 .

Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).

P. Gmeiner, H. Hübner, W. Utz, 2001, Journal of medicinal chemistry.

Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.

Torsten Kuwert, Harald Hübner, Peter Gmeiner, 2007, Journal of medicinal chemistry.

Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine.

H. Lanig, P. Gmeiner, W. Utz, 2001, Journal of medicinal chemistry.

Influence of Nonenzymatic Posttranslational Modifications on Constitution, Oligomerization and Receptor Binding of S100A12

J. Eichler, M. Pischetsrieder, W. Utz, 2014, PloS one.

A Series of 18F‐Labelled Pyridinylphenyl Amides as Subtype‐Selective Radioligands for the Dopamine D3 Receptor

P. Gmeiner, O. Prante, T. Kuwert, 2010, ChemMedChem.